Atlas Trials

Study Evaluating The Safety and Tolerability of HTC-867 in Healthy Japanese Subjects

Clinical trial NCT01268124 · COMPLETED

Trial details

NCT number
NCT01268124
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Schizophrenia
Start date
2008-12-01
Primary completion
2009-04-01
Enrollment
56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.